2025 Annual Report

ADVANCEMENT & TECHNOLOGY

NEW TECHNOLOGY EASES MANAGEMENT OF LIVER DISEASE

pediatric physicians to deftly and comprehensively manage children’s care. Using a technique known as transient elastog raphy, FibroScan was the first FDA-approved device of its kind and is considered an aid to managing liver disease. Quick, noninvasive and painless, it uses an enhanced form of ultrasound to send vibrations into

With obesity in children steadily rising, more young patients are coming to Children’s of Alabama with a form of fatty liver disease that can greatly imperil their health. But determining the progression of liver disease can be a thorny process. To smooth that path, Children’s recently invested in an increasingly popular technology called FibroScan, helping University of Alabama at Birmingham (UAB)

40

CHILDREN’S OF ALABAMA | UAB MEDICINE